Colorcon || One Partner
ACROBiosystems - Survey NA

Projects

The pharmaceutical projects listed in this phase are those that receive periodic global announcements.

EUROAPI Plans €50 Million Investment in Budapest Site to Address Increasing Demand for Prostaglandins

EUROAPI, a pharmaceutical company has recently revealed its plans to invest 50 million in a new stateoftheart production plant at its Budapest site

Colorcon, Inc. Announces Investment in New Film Coating Manufacturing Facility in Malaysia

Colorcon, Inc is delighted to announce its investment in a brand new manufacturing plant located in Johor State, Malaysia

Major Investment of Over 50 Billion Yen Allocated to Strengthen Bio Manufacturing Facilities and Support Swift Launch of In-House Projects

Chugai Pharmaceutical Co, Ltd TOKYO 4519 will invest 50 billion yen to construct new bio APIs and injection buildings at the Utsunomiya Plant, strengthening its manufacturing capabilities

Aurigene Pharmaceutical Services Expanding Biologics CDMO Capacity with New Biomanufacturing Facility

Aurigene Pharmaceutical Services Limited, a subsidiary of Dr Reddys Laboratories, invests $40 million to construct a new development and manufacturing facility

Boehringer Invests US$285 million in New Chemical Innovation Plant in Germany

Boehringer Ingelheim invests US$285 million investment for a new chemical Innovation Plant at Ingelheim, Germany headquarters

Lilly Invests US$1.5 billion for Manufacturing Facilities Expansion in USA

Lilly has announced a significant investment of US$15 billion in new manufacturing facilities located in North Carolina, Indiana, and Ireland

BeiGene Invests US$700 million in Manufacturing, R&D Facility in USA

BeiGene is investing US$700 million for the construction of its manufacturing, and RD facility in New Jersey, USA

Meissner to Build New Manufacturing Facility in USA

Meissner Corporation has invested US$250 million in the development of a new manufacturing site in AthensClarke County, Georgia, USA

Aytu BioPharma Subleases a Portion of Its Manufacturing Facility in USA

Aytu BioPharma and AMT Manufacturing Solutions have recently reached an agreement regarding the subleasing of a portion of Aytus manufacturing facility located in Grand Prairie, Texas, in the United States

Amgen to Start Construction of a New Bio Manufacturing Facility in the USA

Amgen, a biotechnology leader, has announced plans to construct a new biomanufacturing facility in Holly Springs, North Carolina, USA